EVEX

Eve Holding, Inc.

13 filings tracked

industrialsaerospace defenseSMALL ($300M-2B)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

bullishMay 22

Re-election of Class I directors ensures board continuity.

management change

60%

neutralMay 22

Routine ratification of external auditors and governance votes.

regulatory action

30%

bullishMay 22

Re-election of Class I directors ensures board continuity.

management change

60%

neutralMay 22

Routine ratification of external auditors and governance votes.

regulatory action

30%

bullishMay 22

Re-election of Class I directors ensures board continuity.

management change

60%

neutralMay 22

Routine ratification of external auditors and governance votes.

regulatory action

30%

bullishMay 22

Re-election of Class I directors ensures board continuity.

management change

60%

neutralMay 22

Routine ratification of external auditors and governance votes.

regulatory action

30%

bullishMay 22

Re-election of Class I directors ensures board continuity.

management change

60%

neutralMay 22

Routine ratification of external auditors and governance votes.

regulatory action

30%

bullishMay 22

Re-election of Class I directors ensures board continuity.

management change

60%

neutralMay 22

Routine ratification of external auditors and governance votes.

regulatory action

30%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

bearishMay 5

Net loss widened by 41% year-over-year to $68.8 million.

earnings miss

70%

bullishMay 5

Maintained a strong liquidity position of $578 million through debt and equity.

capital raise

80%

bearishMay 5

R&D expenses increased 32% year-over-year to $59.1 million.

margin compression

60%

Filing History

8-KMay 22, 2026

The 8-K filing confirms that Eve Holding has successfully cleared its annual governance hurdles, but the interpretation of this success depends on the investor's lens. While the formal approval of directors and auditors provides a baseline of operational continuity, the shift to a triennial compensation vote and the volume of non-votes introduce questions about the depth of shareholder engagement. Ultimately, the filing removes immediate governance headwinds, shifting the investor focus back to the company's fundamental ability to achieve certification and commercial scale.

10-QMay 5, 2026

The Q1 2026 filing reveals a company in a high-stakes race against time and capital. Eve Holding has successfully secured the initial funding and strategic partnerships necessary to reach the prototyping and testing phase, but the financial cost of this progress is steep. The widening gap between its current pre-revenue status and its 2028 commercialization goal creates a period of extreme vulnerability where any regulatory setback or interest rate hike could jeopardize its stability. Ultimately, the investment thesis rests on whether the 59 successful flight tests and the strategic alliance with Embraer can translate into a certified, marketable product before the current liquidity expires. While the 'fortress' balance sheet provides a temporary shield, the accelerating burn rate and increasing debt service requirements shift the focus from capital accumulation to execution velocity. Investors must weigh the potential of a UAM monopoly against the very real risk of a capital-intensive venture running out of runway.